Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 9Thoracic 4Breast 3Gastrointestinal 2Dermatologic 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Esophageal Neoplasms 10Carcinoma, Hepatocellular 10Rectal Neoplasms 9Colorectal Neoplasms 8Stomach Neoplasms 7Pancreatic Neoplasms 7Colonic Neoplasms 7Lung Neoplasms 6Breast Neoplasms 6Urinary Bladder Neoplasms 4Cholangiocarcinoma 4Carcinoma, Transitional Cell 4Salivary Gland Neoplasms 3Ovarian Neoplasms 3Neuroendocrine Tumors 3Liver Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Anus Neoplasms 3Adenocarcinoma Of Esophagus 3Uterine Cervical Neoplasms 2Tongue Neoplasms 2Thyroid Neoplasms 2Testicular Neoplasms 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2

Interventions

pembrolizumab 43Nivolumab 29atezolizumab 11Specimen Handling 10Cyclophosphamide 10Bevacizumab 10Paclitaxel 9Magnetic Resonance Spectroscopy 9cabozantinib 7Ipilimumab 7Carboplatin 7fludarabine 6durvalumab 6avelumab 6Sunitinib 6Sorafenib 6Oxaliplatin 6Fluorouracil 6Docetaxel 6spartalizumab 5sargramostim 5Leucovorin 5Cisplatin 5Cetuximab 5aldesleukin 4Trastuzumab 4Radiosurgery 4Psychiatric Rehabilitation 4Irinotecan 4Gemcitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Fluorodeoxyglucose F18 × Gastrointestinal × Clear all
NCT04147494 2025-08-12

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Jonsson Comprehensive Cancer Center

Phase EARLY_PHASE1 Active not recruiting
29 enrolled
BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT01806675 2019-10-03

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Stanford University

Phase 1/2 Completed
25 enrolled 14 charts
BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory, Gliosarcoma, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡